Compare MNKD & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNKD | CRON |
|---|---|---|
| Founded | 1991 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2004 | 2015 |
| Metric | MNKD | CRON |
|---|---|---|
| Price | $3.76 | $3.16 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $8.69 | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 1.3M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $348,966,000.00 | $146,587,000.00 |
| Revenue This Year | $35.81 | $26.34 |
| Revenue Next Year | $11.89 | $15.53 |
| P/E Ratio | ★ N/A | $26.29 |
| Revenue Growth | 22.23 | ★ 24.63 |
| 52 Week Low | $2.23 | $2.28 |
| 52 Week High | $6.51 | $3.61 |
| Indicator | MNKD | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 48.16 |
| Support Level | $3.30 | $2.49 |
| Resistance Level | $4.23 | $3.28 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 0.00 | 9.23 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.